User:TheOccasionalHiker/sandbox

Testing for SOX10 has been found to be a sensitive and specific marker of melanoma. SOX10 has also been found to be expressed in all melanoma subtypes and therefore is useful in diagnosing a wide range of melanomas.

S100B was found to be a highly sensitive test for melanoma and there is accumulating evidence that it can also be used as an early biomarker for the return of a tumor. Also to be considered, testing for S100B has a low specificity due to the fact that it can be expressed in other tumor types.

Comments
Thanks for adding your suggestions here. Watch that your citations go after the punctuation (no spaces) like this.1 I have adjusted a few dates on your references. This is not something that you did wrong, just a small glitch with the PMID/DOI tool. JenOttawa (talk) 20:34, 5 November 2018 (UTC)